Showing results (251-260 of 297) with videos related to
Sort By:
Pageof 30
Clinical Pharmacology and Therapeutics|June 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment OutcomesYoungwoo Cho, Sami Elahi, Matthew M Jack, et al.Journal of Clinical Pharmacology|December 6, 2019
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)Manish R Sharma, Shailly Mehrotra, Elizabeth Gray, et al.Cancer Medicine|October 16, 2018
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancerDaniel Shepshelovich, Amanda R Townsend, Osvaldo Espin-Garcia, et al.Investigational New Drugs|April 25, 2022
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human studyPatricia LoRusso, Mark J Ratain, Toshihiko Doi, et al.Clinical and Translational Science|April 22, 2025
Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient PrescribingZhong Huang, Matthew Jack, Kevin J O'Leary, et al.Pharmacogenetics and Genomics|March 20, 2019
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.International Journal of Cancer|September 16, 2021
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimensJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.Cancer|November 25, 2014
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)Jai N Patel, Chen Jiang, Daniel L Hertz, et al.Clinical Pharmacology and Therapeutics|September 28, 2018
A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)Sara R Rashkin, Katherina C Chua, Carol Ho, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicityCharles M Rudin, Wanqing Liu, Apurva Desai, et al.Pageof 30